Bioisosteric replacement of the pyrazole 5-aryl moiety of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A). A novel series of alkynylthiophenes as potent and selective cannabinoid-1 receptor antagonists

Journal of Medicinal Chemistry
Shi-Liang TsengKak-Shan Shia

Abstract

Replacing the conventional pyrazole 5-aryl substituent of 1 (SR141716A) with the 2-thienyl moiety appended with an appropriate alkynyl unit, a novel class of 5-(5-alkynyl-2-thienyl)pyrazole derivatives, behaving as highly potent CB1 receptor antagonists with good CB1/2 selectivity, was discovered, many of which, as typified by compound 18, showed significant weight reduction in diet-induced obese mouse model, thus pharmacologically validating that the bioisosteric replacement described above is viable. Also encouraging was the finding that a subtle structural modification of the newly developed series could result in a distinct difference in the intrinsic property, as demonstrated by compounds 12 (NA) and its methylated structural isomers 15 (PA) and 18 (IA). Moreover, current structure-activity relationship studies revealed that around the pyrazole 5-position of 1, a deep and flat crevice surrounded by a sequence of hydrophobic/aromatic residues as indicated by the CB1-receptor homology model might exist in the binding site.

References

Nov 5, 1997·European Journal of Pharmacology·R S LandsmanH I Yamamura
Mar 3, 1999·Journal of Medicinal Chemistry·R LanA Makriyannis
Mar 22, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·T Kenakin
Dec 19, 1996·Chemical Reviews·George A. Patani, Edmond J. LaVoie
Oct 9, 2002·Current Pharmaceutical Design·Rianne A F de Ligt, Ad P IJzerman
Nov 16, 2002·Angewandte Chemie·Adam F Littke, Gregory C Fu
Apr 20, 2004·Assay and Drug Development Technologies·Heini FrangIlkka Hemmilä
Oct 19, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Sophie J GovaertsDidier M Lambert
Nov 5, 2004·The Journal of Pharmacology and Experimental Therapeutics·Bernard Le Foll, Steven R Goldberg
Jan 11, 2005·Current Medicinal Chemistry·Lídia Moreira Lima, Eliezer J Barreiro
Feb 17, 2005·Bioorganic & Medicinal Chemistry Letters·Christopher W PlummerLex H T Van der Ploeg
May 18, 2005·Drug Discovery Today·Jos H M Lange, Chris G Kruse
May 23, 2006·Nature Medicine·Fatima Teixeira-ClercSophie Lotersztajn
Jul 11, 2006·Journal of Medicinal Chemistry·Jochen AntelUlrich Nordheim
Jul 11, 2006·Journal of Medicinal Chemistry·Anthony L Handlon, Huiqiang Zhou
Jul 11, 2006·Journal of Medicinal Chemistry·Björn M Nilsson
Jul 11, 2006·Journal of Medicinal Chemistry·Ravi P NargundTung M Fong
Jun 1, 2007·Nature Reviews. Drug Discovery·Alisa Opar

❮ Previous
Next ❯

Citations

Jun 13, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Andrea MastinuPaolo Lazzari
Dec 12, 2012·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Yong YuChun Jiang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.